Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2022 - 08 - 04 crawled time : 00:00 save search
MorphoSys AG Reports Second Quarter and First Half 2022 Financial Results
Published: 2022-08-03 (Crawled : 00:00) - biospace.com/
XNCR | $20.11 -1.81% -1.94% 0
|
Health Technology
|
| O: 1.59%
H: 3.56%
C: 0.34%
MOR | $18.02 30K
|
Health Technology
|
| O: 0.55%
H: 4.88%
C: 4.88%
results
Jazz Pharmaceuticals Announces Second Quarter 2022 Financial Results and Affirms 2022 Financial Guidance
Published: 2022-08-03 (Crawled : 00:00) - biospace.com/
JAZZ | $110.65 -0.23% 20K
|
Health Technology
|
| O: 0.05%
H: 0.24%
C: -0.76%
results
Syros Receives Positive Opinion on Orphan Drug Designation from the European Medicines Agency for Tamibarotene for the Treatment of MDS
Published: 2022-08-03 (Crawled : 00:00) - biospace.com/
SYRS | $5.285 -1.95% 32K
|
Health Technology
|
| O: 2.17%
H: 9.03%
C: 5.34%
treatment designation drug positive
Glaukos Corporation Announces Second Quarter 2022 Financial Results
Published: 2022-08-03 (Crawled : 00:00) - biospace.com/
GKOS M | $96.84 -1.42% 0.0% 0
|
Health Technology
|
| O: 1.76%
H: 0.33%
C: -1.59%
corporation results
PacBio Announces Second Quarter 2022 Financial Results
Published: 2022-08-03 (Crawled : 00:00) - biospace.com/
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: 1.96%
H: 2.88%
C: -4.33%
PACB | $1.745 -38.45% 9.4M
|
Health Technology
|
| O: 1.65%
H: 8.01%
C: 5.68%
results
Geron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference
Published: 2022-08-03 (Crawled : 00:00) - biospace.com/
GERN | $3.505 1.59% 350K
|
Health Technology
|
| O: 1.03%
H: 5.61%
C: 4.08%
conference
Personalis Reports Second Quarter 2022 Financial Results
Published: 2022-08-03 (Crawled : 00:00) - biospace.com/
PSNL | $1.23 -2.38% 85K
|
Health Technology
|
| O: 0.74%
H: 9.27%
C: 9.27%
results
Nevro Reports Second Quarter 2022 Financial Results, Provides Third Quarter 2022 Guidance and Updates Full-Year 2022 Guidance
Published: 2022-08-03 (Crawled : 00:00) - biospace.com/
NVRO | $12.33 -1.28% 11K
|
Health Technology
|
| O: 2.13%
H: 0.0%
C: -0.92%
Atara Biotherapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference
Published: 2022-08-03 (Crawled : 00:00) - biospace.com/
ATRA | $0.6786 9.8K
|
Health Technology
|
| O: 1.68%
H: 13.58%
C: 4.97%
conference growth
Arcus Biosciences Reports Second Quarter 2022 Financial Results and Provides a Pipeline Update
Published: 2022-08-03 (Crawled : 00:00) - biospace.com/
RCUS 4 | $16.235 -0.34% 23K
|
Health Technology
|
| O: 2.37%
H: 5.92%
C: 1.58%
arcus update results
Dedicated Incident Channel Improvements for Slack on Webhooks V3 – Early Access by Jorge Villamariona
Published: 2022-08-03 (Crawled : 00:00) - pagerduty.com
PD 4 | $20.595 -1.74% 47K
|
Technology Services
|
| O: 1.95%
H: 3.8%
C: 3.43%
Atento Reports Fiscal 2022 Second Quarter and First Half Results
Published: 2022-08-03 (Crawled : 00:00) - prnewswire.com
ATTO | $0.4715 49K
|
Commercial Services
|
| O: -12.44%
H: 0.0%
C: -10.36%
results
Chronic Disease Management Market to Reach $14.88 Bn, Globally, by 2031 at 11.8% CAGR: Allied Market Research
Published: 2022-08-03 (Crawled : 00:00) - prnewswire.com
PHG | $20.32 -0.44% 94K
|
Health Technology
|
| O: 1.75%
H: 0.39%
C: -0.2%
INFY | $17.08 -1.1% 800K
|
Technology Services
|
| O: 0.35%
H: 0.5%
C: -0.1%
PEGA | $57.9 -0.96% 6.7K
|
Technology Services
|
| O: 0.17%
H: 1.49%
C: -4.16%
management research disease market
EISAI PRESENTS NEW FINDINGS ON LECANEMAB'S INVESTIGATIONAL SUBCUTANEOUS FORMULATION AND MODELING SIMULATION OF APOE4 GENOTYPE ON ARIA-E INCIDENCE AT THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE (AAIC) 2022
Published: 2022-08-03 (Crawled : 00:00) - prnewswire.com
BIIB | $195.56 -0.63% 13K
|
Health Technology
|
| O: 0.53%
H: 1.92%
C: 1.19%
conference alzheimer's international lecanemab
B2Gold Reports Strong Q2 2022 Results with Cash Operating Costs and All-In Sustaining Costs Below Budget; Full-year 2022 Total Consolidated Gold Production and Cost Guidance Remains Unchanged
Published: 2022-08-03 (Crawled : 00:00) - prnewswire.com
AIRRF | $0.5097 0.1% 0
|
Non-Energy Minerals
|
| O: 1.15%
H: 11.8%
C: 11.8%
AU | $23.81 -0.17% -1.01% 130K
|
Non-Energy Minerals
|
| O: 1.08%
H: 2.97%
C: 1.79%
BTG | $2.71 -6.23% -1.48% 170K
|
Non-Energy Minerals
|
| O: 0.88%
H: 2.32%
C: -0.87%
results
TOMORROW CRYPTO GROUP INC. TO BECOME PUBLICLY TRADED THROUGH PROPOSED MERGER WITH GLOBALINK INVESTMENT INC.
Published: 2022-08-03 (Crawled : 00:00) - globenewswire.com
GLLI | $11.05 22K
|
n/a
|
| O: 0.15%
H: 0.0%
C: -0.3%
CRCW | $0.0017 0
|
Information
|
| O: -4.67%
H: 11.89%
C: 0.0%
group
Gainers vs Losers
| 40% | 60% |
Top 10 Gainers
TPET | $0.4801 107.75% 16M
|
n/a
WISA 4 | $3.17 81.14% 36M
|
Electronic Technology
PALI | $7.41 78.13% 14M
|
Manufacturing
SPCB | $0.4278 55.0% 17M
|
Electronic Technology
PRSO | $1.79 40.95% 25M
|
Manufacturing
JAGX | $0.1668 40.4% 110M
|
Health Technology
MCBC | $13.84 39.38% 450K
|
Finance
SNGX | $0.5155 33.52% 3.9M
|
Health Technology
SNPO | $10.57 29.85% 570K
|
ITCI | $80.21 23.86% 2M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.